Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Weekly cadence·125 episodes·Last published 3mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 1 epsHosts
Not detected.
Recent guests
Recent episodes
In conversation with... Jenny Clarke and Herve Semukunzi
Mar 10, 2026
20m 59s
In conversation with... Julia Moore Vogel and Danilo Buonsenso
Dec 19, 2025
Unknown duration
In Conversation with Steven Tong and Joshua Davis
Oct 23, 2025
Unknown duration
In conversation with... Anna Odone, Jesus Rodriguez-Manzano, and Alex Howard
Sep 17, 2025
Unknown duration
In conversation with... Catherine Liu and Joshua Hill
Aug 12, 2025
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
Resolving iTunes ID\u2026 if this persists, the podcast may not be indexed on Apple Podcasts.
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 3/10/26 | In conversation with... Jenny Clarke and Herve Semukunzi✨ | mpoxvaccines+4 | Dr Jenny ClarkeHerve Semukunzi | Infection- and vaccine-induced mpox antibodies: validation of a combined mpox IgG ELISA during the clade 1b outbreak in Rwanda | — | mpoxantibodies+5 | — | 20m 59s | |
| 12/19/25 | In conversation with... Julia Moore Vogel and Danilo Buonsenso | Dr Julia Moore Vogel and Dr Danilo Buonsenso discuss various aspects of long COVID including epidemiology, pathophysiology, underlying mechanisms, management, latest research developments, difficulties in conducting clinical trials, and future research priorities. | — | ||||||
| 10/23/25 | In Conversation with Steven Tong and Joshua Davis | Professors Steven Tong and Joshua Davis discuss all aspects of adaptive platform trials including advantages, disadvantages, differences from conventional trials, and tips for setting up and assessing them. | — | ||||||
| 9/17/25 | In conversation with... Anna Odone, Jesus Rodriguez-Manzano, and Alex Howard | Series authors discuss their papers on artificial intelligence and infectious diseases intended to support the infectious diseases community in understanding this evolving landscape. | — | ||||||
| 8/12/25 | In conversation with... Catherine Liu and Joshua Hill | Drs Catherine Liu and Joshua Hill of the Fred Hutchinson Cancer Center discuss their new Series of papers on the prevention and management of infections in people who are immunocompromised, with a focus on prevention of infections and diagnostic and antimicrobial stewardship. | — | ||||||
| 7/10/25 | In conversation with... Lilian Tina Minja and Norbert Heinrich | Lilian Tina Minja and Norbert Heinrich discuss the SUDUCO and DECODE trials in The Lancet Infectious Diseases on two new promising TB drugs, sutezolid and delpazolid, respectively. They also discuss the wider implications of the findings of these trials for TB drug development and treatment. | — | ||||||
| 6/11/25 | In conversation with... Leonardo Basso and Juan Pablo Torres | Leonardo Basso and Juan Pablo Torres discuss their study in The Lancet Infectious Diseases on the effectiveness and impact of the first season of Chile's national immunisation programme with nirsevimab. They discuss the evidence that led to the design and implementation of the programme, its impact on RSV burden and the Chilean health system, and lessons for other countries in the region and beyond. | — | ||||||
| 4/14/25 | In conversation with... Jan Felix Drexler and Fernando Bozza | Jan Felix Drexler and Fernando Bozza discuss their recent study published in the journal— “The spatio-temporal ecology of Oropouche virus: a laboratory-based modelling study across Latin America” and its wider implications for Oropouche virus and other arboviruses transmission, expansion, surveillance, and control. | — | ||||||
| 2/24/24 | In Conversation With… Prasad Kulkarni on a dengue monoclonal antibody | Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development. | — | ||||||
| 1/9/24 | In conversation with... Oriol Mitjà | Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphilis. | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 1/27/23 | In conversation with... Luciano Moreira and Henrik Salje | Luciano Moreira and Henrik Salje discuss a new article in The Lancet Infectious Diseases describing the use of the Wolbachia bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil. | — | ||||||
| 9/26/22 | In conversation with... Richard Maude | Richard Maude discusses a new article in The Lancet Infectious Diseases that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia. | — | ||||||
| 7/15/22 | In conversation with... Ben Cowling | Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong. | — | ||||||
| 5/26/22 | In conversation with... Hugh Adler | Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021. | — | ||||||
| 12/15/21 | In conversation with... Beate Kampmann, Karen Keddy, and Peter Ghazal | Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and EBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICs | — | ||||||
| 10/12/21 | In conversation with... Laura Cooper and Sam Okiror | A new Article in The Lancet Infectious Diseases highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa. | — | ||||||
| 8/20/21 | In conversation with... Paul Chapman | Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated Necator americanus hookworm larvae. | — | ||||||
| 5/28/21 | In conversation with... Josep Llibre | Josep Llibre discusses a trial on the impact of same-day testing for SARS-CoV-2 infection before a concert on new COVID-19 cases in Ba rcelona, Spain. | — | ||||||
| 3/26/21 | In Conversation With... Yap Boum | Yap Boum (MSF) discusses his study done in Cameroon, which developed a promising testing strategy for COVID-19 to optimise the available resource. | — | ||||||
| 7/25/19 | Antimalarial resistance in southeast Asia | Two studies in The Lancet Infectious Diseases describe how the spread of resistance to both dihydroartemisinin and piperaquine is compromising malaria therapy in South-East Asia | — | ||||||
| 10/4/18 | Trial in phage therapy for burn infections | A trial investigates the use of a cocktail of phages for the therapy of infections in patients with burns. | — | ||||||
| 6/21/18 | Pandemic influenza: 100 years | Editor of The Lancet Infectious Diseases, John McConnell, discusses the 1918 influenza pandemic and the lessons that can be learnt from it with John Oxford and Jeffery Taubenberger. | — | ||||||
| 2/14/18 | Bedaquiline and delamanid combination for drug-resistant TB: The Lancet Infectious Diseases: February 13, 2018 | Amir Shroufi discusses the early results assessing the safety and efficacy of the combination of bedaquiline and delamanid against drug-resistant tuberculosis. | — | ||||||
| 1/10/18 | MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018 | John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS. | — | ||||||
| — | In conversation with... Sofia Viegas and Stefan Niemann | Sofia Viegas and Stefan Niemann discuss a new article in The Lancet Infectious Diseases about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis. | — | ||||||
Showing 25 of 125
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.